• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Unison Capital

PE-owned Japanese drug maker seeks bankruptcy protection
PE-owned Japanese drug maker seeks bankruptcy protection

Kyowa Pharmaceutical Industry, a Japanese generic drug manufacturer owned by Unison Capital, has applied for alternative dispute resolution, an out-of-court process that allows companies to continue operations while negotiating with creditors on a restructuring....

  • North Asia
  • 07 August 2023
Korea's UCK Partners surpasses $770m on Fund III
Korea's UCK Partners surpasses $770m on Fund III

UCK Partners, a South Korean private equity firm formerly known as Unison Capital Korea, has accumulated approximately KRW 1trn (USD 777m) across two incremental closes on its third fund.

  • North Asia
  • 02 August 2023
Japanese GPs maintain strong investment pace - AVCJ Forum
Japanese GPs maintain strong investment pace - AVCJ Forum

Deployment remains robust in Japan’s mid-cap space with private equity firms continuing to see plentiful opportunities in carve-outs and founder-succession situations, the AVCJ Private Equity & Venture Forum Japan 2023 heard.

  • North Asia
  • 07 July 2023
MBK, Unison Korea pursue dental implant buyout
MBK, Unison Korea pursue dental implant buyout

MBK Partners and Unison Capital Korea have launched a tender offer for Osstem Implant, a Korea-based manufacturer of dental implants, that values the company at approximately KRW 2.85trn (USD 2.3bn).

  • North Asia
  • 30 January 2023
MBK buys Korea dental scanning player Medit, Unison exits
MBK buys Korea dental scanning player Medit, Unison exits

MBK Partners has agreed to buy Medit, a South Korea-based manufacturer of 3D dental scanners, for a valuation of approximately KRW 2.4trn (USD 1.88bn). The transaction facilitates an exit for Unison Capital’s Korea business.

  • North Asia
  • 02 January 2023
Unison Korea targets $680m for Fund III

Unison Capital is targeting KRW 800bn-KRW 900bn (USD 603m-USD 680m) for its third Korea fund, nearly twice what was raised in the previous vintage.

  • North Asia
  • 25 November 2022
Japan PE sees digitalisation as national imperative – AVCJ Forum
Japan PE sees digitalisation as national imperative – AVCJ Forum

Digital transformation is an urgent social issue as much as an operational one, Japan-focused investors told the AVCJ Private Equity & Venture Forum.

  • North Asia
  • 22 November 2022
Currency, exit, labour issues worry Japanese GPs - AVCJ Forum
Currency, exit, labour issues worry Japanese GPs - AVCJ Forum

Currency depreciation, dwindling domestic IPO opportunities, and labour shortages are all their toll on the portfolios of middle-market Japanese private equity firms, the AVCJ Japan Forum heard.

  • North Asia
  • 05 October 2022
Japan's D Capital nears target for debut PE fund
Japan's D Capital nears target for debut PE fund

Japan’s D Capital, a private equity firm specialising in digital transformation that spun out from Unison Capital last year, has raised JPY 26bn (USD 188m) for its debut fund against a target of JPY 30bn.

  • North Asia
  • 01 September 2022
Activists, growth equity among Japan deal drivers - AVCJ Forum

Private equity deal flow in Japan is likely to increase in the coming years, spurred by factors ranging from activist investors to the rise of growth equity, industry participants told the AVCJ Japan Forum.

  • North Asia
  • 08 November 2021
Weekly digest - July 14 2021
Weekly digest - July 14 2021

  • Region
  • 14 July 2021
GP profile: Unison Capital
GP profile: Unison Capital

Unison Capital hones its game and holds tight to its heritage as one of the pioneers of private equity in Japan, even as its tentacles begin to span the breadth of Asia

  • North Asia
  • 13 July 2021
Unison makes two Japan healthcare acquisitions
Unison makes two Japan healthcare acquisitions

Japan’s Unison Capital has confirmed two local healthcare deals in the space of a week with pharmacy chain Reliance and outpatient nursing provider N Field.

  • North Asia
  • 31 March 2021
Q&A: Unison Capital's Tatsuo Kawasaki

Tatsuo Kawasaki, a partner at Unison Capital, on supporting existing investments and making new ones, expectations of distress in Japan, and why a platform approach makes sense for healthcare

  • North Asia
  • 09 October 2020
ASEAN to see rise in opportunities despite high valuations – AVCJ Forum
ASEAN to see rise in opportunities despite high valuations – AVCJ Forum

Industry professionals at the AVCJ Southeast Asia Virtual Forum predicted a rise in regional acquisition opportunities although valuations remain stubbornly high for now.

  • Southeast Asia
  • 22 July 2020
Coronavirus in Asia: Ongoing analysis
Coronavirus in Asia: Ongoing analysis

Coronavirus concerns among GPs not solely focused on China vary based on their direct or indirect exposure to China, but gauging private equity responses to the crisis is like chasing a moving target

  • North Asia
  • 11 March 2020
Portfolio: Unison Capital and CHCP

Through its Community Healthcare Coordination Platform, Unison Capital wants to bring efficiencies and economies of scale to parts of Japan’s healthcare sector that have been isolated from private markets

  • North Asia
  • 14 February 2020
AVCJ Awards 2019: Exit of the Year - Small Cap: Gong Cha
AVCJ Awards 2019: Exit of the Year - Small Cap: Gong Cha

Unison Capital took a Korean game plan global with the Gong Cha bubble tea chain. Attention to local tastes, however, was the key to the enterprise

  • North Asia
  • 19 January 2020
Unison agrees $526m Japan pharma carve-out

Unison Capital has agreed to buy Kyowa Pharmaceutical Industry, a Japanese subsidiary of India-headquartered drug manufacturer Lupin for an enterprise valuation of JPY57.4 billion ($526 million).

  • North Asia
  • 12 November 2019
Deal focus: Gong Cha's global push pays off for Unison

Unison Capital achieves a rare feat in helping the Korea franchise of bubble tea retailer Gong Cha take over its Taiwanese parent before facilitating a sale to TA Associates. Entering Japan has been a key value-add

  • North Asia
  • 04 September 2019
TA invests in Unison-backed Gong Cha - update

TA Associates has acquired a controlling stake in Gong Cha, the Taiwan-based bubble tea chain backed by Unison Capital.

  • North Asia
  • 27 August 2019
Unison launches Japan hospital roll-up platform

Unison Capital has made the first investment from a newly created platform that will pursue a roll-up strategy in Japan’s hospital industry, with JPY50-60 billion ($467-560 million) set to be committed over the next five years.

  • North Asia
  • 02 August 2019
Unison buys Japanese hair treatment specialist

Unison Capital has acquired Pyuru, a Japanese producer of hair care and cosmetics products best known for a naturally-derived treatment for graying hair.

  • North Asia
  • 24 June 2019
Japan secondary buyouts: Between friends

Negative perceptions and local sensitivities have stymied the development of secondary buyouts in Japan. International GPs – plus some of their domestic peers – have the firepower to drive change

  • North Asia
  • 24 June 2019
123
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013